FSA is consulting on draft guidance on transaction reporting of Chi-X Centrally Cleared CFDs. FSA wants to clarify in its guidance how these new instruments launched by Chi-X on 8 November should be reported under SUP 17 and by whom. It asks for responses by 22 November.